Literature DB >> 11810290

Familial idiopathic basal ganglia calcification (Fahr's disease) without neurological, cognitive and psychiatric symptoms is not linked to the IBGC1 locus on chromosome 14q.

Henry Brodaty1, Philip Mitchell, Georgina Luscombe, John J Kwok, Renee F Badenhop, Rod McKenzie, Peter R Schofield.   

Abstract

Idiopathic basal ganglia calcification (IBGC) is characterised by radiological, neurological, cognitive and psychiatric abnormalities. The associations between these abnormal phenotypes and abnormal genes remain unclear despite the recent mapping to chromosome 14q of a susceptibility locus for IBGC ( IBGC1). We identified two siblings, from a large multigenerational pedigree, who had both been diagnosed with radiological IBGC, dementia, bipolar affective disorder and Parkinsonism. We assessed (1) other family members to determine whether these four phenotypes were co-segregating as symptoms of IBGC, and (2) possible IBGC linkage to the IBGC1 locus on chromosome 14q or to any known or potential dementia genes. Nine second-generation and 21 third-generation members received radiological, neurological, neuropsychological and psychiatric assessments. We genotyped all family members for microsatellite markers at the IBGC1 locus and polymorphisms of the ApoE, VLDL, alpha1-ACT, BChE-K, APP, PS1, PS2 and tau genes and tested these for linkage to IBGC, dementia and bipolar disorder. Of the ten family members with radiological intracranial calcification, all except the two index cases were normal. There was no significant association between IBGC status and severe cognitive impairment or dementia ( P=0.335) or bipolar affective disorder or Parkinsonism ( P=1.0). Linkage to the IBGC1 locus was excluded. Of the eight dementia gene markers tested, the only positive LOD score was for the ApoE epsilon4 polymorphism and dementia/severe cognitive impairment. We have identified a form of IBGC in which calcification is inherited independently of neurological, cognitive and psychiatric symptoms. This may represent a second locus for this disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11810290     DOI: 10.1007/s00439-001-0650-x

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  18 in total

1.  Analysis of candidate genes at the IBGC1 locus associated with idiopathic basal ganglia calcification ("Fahr's disease").

Authors:  J R M Oliveira; M J Sobrido; E Spiteri; S Hopfer; G Meroni; E Petek; M Baquero; D H Geschwind
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

2.  Fahr's disease: bilateral symmetrical striopallidodentate calcification in two brothers with two distinct presentations.

Authors:  Abdalla Bowirrat; Mustafa Yassin; Faozi Artoul; Suheil Artul
Journal:  BMJ Case Rep       Date:  2013-09-06

3.  Exclusion of linkage to chromosomes 14q, 2q37 and 8p21.1-q11.23 in a Serbian family with idiopathic basal ganglia calcification.

Authors:  Vladimir S Kostić; Milica Lukić-Ječmenica; Ivana Novaković; Valerija Dobričić; Lela Brajković; Maja Krajinović; Christine Klein; Aleksandra Pavlović
Journal:  J Neurol       Date:  2011-03-16       Impact factor: 4.849

4.  Fahr's syndrome: a rare clinico-radiologic entity.

Authors:  Rajul Rastogi; A K Singh; U C Rastogi; Chander Mohan; Vaibhav Rastogi
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Analysis of the CTAGE5 P521A variation with the risk of familial idiopathic basal ganglia calcification in an Iranian population.

Authors:  Kioomars Saliminejad; Fereshteh Ashtari; Koroosh Kamali; Haleh Edalatkhah; Hamid Reza Khorram Khorshid
Journal:  J Mol Neurosci       Date:  2012-10-05       Impact factor: 3.444

6.  Fahr's disease in two siblings in a family: A case report.

Authors:  Hong Wang; Bei Shao; Liuqing Wang; Qiang Ye
Journal:  Exp Ther Med       Date:  2015-03-16       Impact factor: 2.447

7.  Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.

Authors:  Sandy Chan Hsu; Renee L Sears; Roberta R Lemos; Beatriz Quintáns; Alden Huang; Elizabeth Spiteri; Lisette Nevarez; Catherine Mamah; Mayana Zatz; Kerrie D Pierce; Janice M Fullerton; John C Adair; Jon E Berner; Matthew Bower; Henry Brodaty; Olga Carmona; Valerija Dobricić; Brent L Fogel; Daniel García-Estevez; Jill Goldman; John L Goudreau; Suellen Hopfer; Milena Janković; Serge Jaumà; Joanna C Jen; Suppachok Kirdlarp; Joerg Klepper; Vladimir Kostić; Anthony E Lang; Agnès Linglart; Melissa K Maisenbacher; Bala V Manyam; Pietro Mazzoni; Zofia Miedzybrodzka; Witoon Mitarnun; Philip B Mitchell; Jennifer Mueller; Ivana Novaković; Martin Paucar; Henry Paulson; Sheila A Simpson; Per Svenningsson; Paul Tuite; Jerrold Vitek; Suppachok Wetchaphanphesat; Charles Williams; Michele Yang; Peter R Schofield; João R M de Oliveira; María-Jesús Sobrido; Daniel H Geschwind; Giovanni Coppola
Journal:  Neurogenetics       Date:  2013-01-20       Impact factor: 2.660

8.  2q37 as a susceptibility locus for idiopathic basal ganglia calcification (IBGC) in a large South Tyrolean family.

Authors:  Claudia Béu Volpato; Alessandro De Grandi; Ebba Buffone; Maurizio Facheris; Uwe Gebert; Günther Schifferle; Rudolf Schönhuber; Andrew Hicks; Peter P Pramstaller
Journal:  J Mol Neurosci       Date:  2009-11       Impact factor: 3.444

Review 9.  The genetics of primary familial brain calcifications.

Authors:  Ana Westenberger; Christine Klein
Journal:  Curr Neurol Neurosci Rep       Date:  2014-10       Impact factor: 5.081

10.  SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia.

Authors:  Matt Baker; Audrey J Strongosky; Monica Y Sanchez-Contreras; Shan Yang; Will Ferguson; Donald B Calne; Susan Calne; A Jon Stoessl; Judith E Allanson; Daniel F Broderick; Michael L Hutton; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Neurogenetics       Date:  2013-10-18       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.